AT&T Inc. vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? AT&T Inc. trades at $23.23 (market cap $167.68B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: AT&T Inc. is far larger — about 2.9× Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s market cap, and AT&T Inc. pays the higher dividend (4.54%). Which is the better fit depends on your goals — on Pluang, investors hold AT&T Inc. for 118 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| T | TAK | |
|---|---|---|
Market Cap | $167.68B | $58.16B |
Volume | 27,788,850 | 2,467,530 |
Sector | Media | Health |
52-Week High | $29.10 | $19.05 |
52-Week Low | $20.49 | $13.23 |
Typical Hold Time | 118 Days | 0 Days |
Enterprise Value | $313.00B | $86.04B |
Dividend Yield | 4.54% | 3.36% |
Signals from Pluang's Aura AI — not financial advice
AT&T (T) trades at $24.885, up 1.88% in the last session, with a bearish technical signal but strong fundamentals including a P/E of 8.08 and net income margin of 16.94%. Recent earnings beats and a $3 billion fiber deal with Corning highlight growth initiatives, while cash flow improved to $15.12B in 2025.
The stock offers value with a 4%+ dividend yield and analyst consensus price target of $27.61, but faces risks from high debt and competitive pressures. Upside depends on execution in fiber and wireless, while sentiment is mixed amid dividend sustainability concerns.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →